Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 53.47
+2.19 (4.27%)
At close: Mar 10, 2026
SHA:688193 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | - | 261.58 | 609.57 | 298.93 | 197.94 | Upgrade
|
| Short-Term Investments | - | 29.2 | 125.66 | - | - | Upgrade
|
| Trading Asset Securities | - | 510.96 | 50.21 | 530.98 | - | Upgrade
|
| Cash & Short-Term Investments | 783.46 | 801.74 | 785.44 | 829.91 | 197.94 | Upgrade
|
| Cash Growth | -2.28% | 2.08% | -5.36% | 319.27% | 15.10% | Upgrade
|
| Accounts Receivable | - | 49.37 | 77.6 | 105.13 | 55.5 | Upgrade
|
| Other Receivables | - | 2.64 | 4.83 | 3.54 | 4.29 | Upgrade
|
| Receivables | - | 52.01 | 82.43 | 108.66 | 59.79 | Upgrade
|
| Inventory | - | 25.14 | 28.6 | 28.29 | 19.39 | Upgrade
|
| Other Current Assets | - | 5.86 | 2.67 | 5.72 | 5.42 | Upgrade
|
| Total Current Assets | - | 884.74 | 899.14 | 972.58 | 282.54 | Upgrade
|
| Property, Plant & Equipment | - | 82.22 | 92.72 | 100.91 | 87.64 | Upgrade
|
| Long-Term Investments | - | - | 40.77 | - | - | Upgrade
|
| Other Intangible Assets | - | 0.41 | 0.45 | 0.66 | 0.6 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 20.24 | 12.96 | 9.63 | 3.23 | Upgrade
|
| Long-Term Deferred Charges | - | 6.74 | 8.3 | 3.73 | 3.92 | Upgrade
|
| Other Long-Term Assets | - | - | 0.38 | 1.21 | 0.68 | Upgrade
|
| Total Assets | - | 994.36 | 1,055 | 1,089 | 378.61 | Upgrade
|
| Accounts Payable | - | 3.04 | 4.09 | 11.38 | 9.84 | Upgrade
|
| Accrued Expenses | - | 55.68 | 58.65 | 65.77 | 36.96 | Upgrade
|
| Current Portion of Leases | - | 1.91 | 2.93 | 2.6 | 1.88 | Upgrade
|
| Current Income Taxes Payable | - | 0.25 | 1 | 1.12 | 2.39 | Upgrade
|
| Current Unearned Revenue | - | 9.01 | 5.58 | 7.33 | 9.22 | Upgrade
|
| Other Current Liabilities | - | 4.52 | 6.21 | 7.26 | 6.02 | Upgrade
|
| Total Current Liabilities | - | 74.42 | 78.45 | 95.46 | 66.31 | Upgrade
|
| Long-Term Leases | - | 2.33 | 4.09 | 7.91 | 2.11 | Upgrade
|
| Long-Term Unearned Revenue | - | 5.72 | 9.42 | 22.2 | 22.2 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 1.72 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.01 | 0.01 | 0.05 | 0.24 | Upgrade
|
| Total Liabilities | - | 82.48 | 91.97 | 127.34 | 90.86 | Upgrade
|
| Common Stock | - | 40 | 40 | 40 | 30 | Upgrade
|
| Additional Paid-In Capital | - | 777.44 | 773.7 | 776.23 | 135.44 | Upgrade
|
| Retained Earnings | - | 129.87 | 149.39 | 146.13 | 122.8 | Upgrade
|
| Treasury Stock | - | -35.66 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | 0.23 | -0.35 | -0.97 | -0.49 | Upgrade
|
| Shareholders' Equity | 918.36 | 911.88 | 962.74 | 961.38 | 287.75 | Upgrade
|
| Total Liabilities & Equity | - | 994.36 | 1,055 | 1,089 | 378.61 | Upgrade
|
| Total Debt | 4.35 | 4.24 | 7.02 | 10.51 | 3.99 | Upgrade
|
| Net Cash (Debt) | 779.11 | 797.51 | 778.42 | 819.4 | 193.95 | Upgrade
|
| Net Cash Growth | -2.31% | 2.45% | -5.00% | 322.47% | 15.36% | Upgrade
|
| Net Cash Per Share | 19.66 | 20.42 | 19.79 | 21.42 | 6.39 | Upgrade
|
| Filing Date Shares Outstanding | 41.59 | 38.71 | 40 | 40 | 30 | Upgrade
|
| Total Common Shares Outstanding | 38.78 | 38.71 | 40 | 40 | 30 | Upgrade
|
| Working Capital | - | 810.33 | 820.69 | 877.12 | 216.23 | Upgrade
|
| Book Value Per Share | 23.68 | 23.56 | 24.07 | 24.03 | 9.59 | Upgrade
|
| Tangible Book Value | 918.05 | 911.47 | 962.29 | 960.72 | 287.15 | Upgrade
|
| Tangible Book Value Per Share | 23.67 | 23.55 | 24.06 | 24.02 | 9.57 | Upgrade
|
| Buildings | - | 58.85 | 58.85 | 58.47 | 58.47 | Upgrade
|
| Machinery | - | 74.51 | 71.85 | 67.39 | 48.02 | Upgrade
|
| Construction In Progress | - | 0.41 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.